Dabcyl-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Edans
CAS: 396716-14-6
Rif. 3D-SFQ-3764-PI
1mg | 435,00 € | ||
5mg | 1.385,00 € |
Informazioni sul prodotto
- DABCYL-TNF-alpha-EDANS (-4 to +6)
- human Dabcyl-LAQAVRSSSR-Edans
- Adam-17 Substrate Ii, Fluorogenic
- Adam-17 Substrate Iii, Fluorogenic
- Dabcyl-Tnf-Alpha-Edans (-4 To +6) (Human)
- Dabcyl-Tumor Necrosis Factor-Alpha-Edans (-4 To +6) (Human)
- Dabcyl-Laqavrsssr-Edans
- Tnf-Alpha Convertase Enzyme Substrate, Fluorogenic
- Tnf-Alpha Convertase Enzyme Substrate Ii, Fluorogenic
- L-Argininamide, N-[4-[[4-(Dimethylamino)Phenyl]Azo]Benzoyl]-L-Leucyl-L-Alanyl-L-Glutaminyl-L-Alanyl-L-Valyl-L-Arginyl-L-Seryl-L-Seryl-L-Seryl-N-[2-[(5-Sulfo-1-Naphthalenyl)Amino]Ethyl]-
- Vedi altri sinonimi
TNF-a is shed from cell membranes by TNF-a-FW cleaving enzyme (TACE). Incubation of the TACE substrate with recombinant human TACE gives a specific cleavage to restore the quenched fluorescence. The substrate is widely used to screen inhibitors of TNF-α converting enzyme (TACE, ADAM17 endopeptidase) activity. On application is its use as a TACE FRET Substrate I and it is available as a Trifluoroacetate Salt.
Proprietà chimiche
Richiesta tecnica su: 3D-SFQ-3764-PI Dabcyl-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Edans
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.